Ameriprise’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$167K Sell
73,400
-30,600
-29% -$88.9K ﹤0.01% 3909
2025
Q4
$333K Sell
104,000
-173
-0.2% -$434 ﹤0.01% 3771
2025
Q3
$261K Sell
104,173
-38,800
-27% -$120K ﹤0.01% 3833
2025
Q2
$475K Hold
142,973
﹤0.01% 3546
2025
Q1
$599K Sell
142,973
-3,400
-2% -$15.4K ﹤0.01% 3413
2024
Q4
$706K Hold
146,373
﹤0.01% 3398
2024
Q3
$539K Sell
146,373
-29,700
-17% -$105K ﹤0.01% 3448
2024
Q2
$713K Buy
176,073
+75,214
+75% +$321K ﹤0.01% 3306
2024
Q1
$483K Sell
100,859
-65,623
-39% -$382K ﹤0.01% 3430
2023
Q4
$1.26M Buy
166,482
+114,100
+218% +$937K ﹤0.01% 3098
2023
Q3
$537K Buy
+52,382
New +$646K ﹤0.01% 3384
2023
Q2
Sell
-87,367
Closed -$1.42M 3982
2023
Q1
$1.42M Sell
87,367
-9,929
-10% -$187K ﹤0.01% 3005
2022
Q4
$1.72M Buy
97,296
+434
+0.4% +$8.62K ﹤0.01% 2876
2022
Q3
$1.89M Sell
96,862
-29,553
-23% -$627K ﹤0.01% 2812
2022
Q2
$2.52M Buy
126,415
+12,385
+11% +$277K ﹤0.01% 2732
2022
Q1
$2.94M Buy
114,030
+1,350
+1% +$35K ﹤0.01% 2736
2021
Q4
$2.85M Sell
112,680
-2,563
-2% -$70.9K ﹤0.01% 2816
2021
Q3
$3.1M Buy
115,243
+11,237
+11% +$324K ﹤0.01% 2684
2021
Q2
$3.31M Sell
104,006
-3,121
-3% -$99.1K ﹤0.01% 2695
2021
Q1
$3.77M Sell
107,127
-57,311
-35% -$1.99M ﹤0.01% 2562
2020
Q4
$5.27M Buy
164,438
+9,238
+6% +$285K ﹤0.01% 2236
2020
Q3
$4.91M Sell
155,200
-27,261
-15% -$902K ﹤0.01% 2103
2020
Q2
$6.5M Sell
182,461
-7,076
-4% -$246K ﹤0.01% 1877
2020
Q1
$5.45M Sell
189,537
-13,423
-7% -$352K ﹤0.01% 1853
2019
Q4
$4.77M Buy
202,960
+11,639
+6% +$261K ﹤0.01% 2262
2019
Q3
$3.45M Sell
191,321
-12,648
-6% -$209K ﹤0.01% 2408
2019
Q2
$3.2M Buy
203,969
+71,351
+54% +$1.4M ﹤0.01% 2504
2019
Q1
$3.02M Sell
132,618
-15,975
-11% -$360K ﹤0.01% 2534
2018
Q4
$3.46M Sell
148,593
-4,143
-3% -$111K ﹤0.01% 2362
2018
Q3
$5.04M Sell
152,736
-38,081
-20% -$1.42M ﹤0.01% 2330
2018
Q2
$8.41M Sell
190,817
-98,972
-34% -$3.83M ﹤0.01% 1879
2018
Q1
$12.1M Buy
289,789
+11,580
+4% +$535K 0.01% 1518
2017
Q4
$12.7M Sell
278,209
-7,626
-3% -$300K 0.01% 1425
2017
Q3
$9.47M Buy
285,835
+93,699
+49% +$3.81M ﹤0.01% 1619
2017
Q2
$7.8M Buy
192,136
+32,916
+21% +$1.02M ﹤0.01% 1751
2017
Q1
$3.18M Buy
159,220
+9,164
+6% +$194K ﹤0.01% 2342
2016
Q4
$3.46M Sell
150,056
-50,489
-25% -$1.08M ﹤0.01% 2332
2016
Q3
$4.06M Sell
200,545
-65,705
-25% -$1.32M ﹤0.01% 2142
2016
Q2
$5M Sell
266,250
-242,711
-48% -$4.46M ﹤0.01% 1942
2016
Q1
$9.12M Buy
508,961
+174,424
+52% +$2.99M 0.01% 1493
2015
Q4
$5.73M Buy
334,537
+270
+0.1% +$4.54K ﹤0.01% 1912
2015
Q3
$5.39M Buy
334,267
+137,210
+70% +$2.3M ﹤0.01% 1959
2015
Q2
$3.4M Buy
197,057
+75,006
+61% +$1.26M ﹤0.01% 2398
2015
Q1
$2.02M Buy
122,051
+32,319
+36% +$501K ﹤0.01% 2592
2014
Q4
$1.29M Sell
89,732
-142
-0.2% -$1.91K ﹤0.01% 2748
2014
Q3
$1.22M Sell
89,874
-238,614
-73% -$3.32M ﹤0.01% 2698
2014
Q2
$4.43M Buy
328,488
+4,865
+2% +$64.2K ﹤0.01% 2155
2014
Q1
$4.34M Sell
323,623
-45,194
-12% -$626K ﹤0.01% 2118
2013
Q4
$6.13M Buy
368,817
+277,172
+302% +$4.33M ﹤0.01% 1868
2013
Q3
$1.49M Sell
91,645
-1,060
-1% -$16.5K ﹤0.01% 2554
2013
Q2
$1.17M Buy
+92,705
New +$1.21M ﹤0.01% 2557

Other funds holding PETS

Ameriprise's PETS Position: Q1 2026 in Review

Ameriprise reduced its PetMed Express (PETS) stake by 29% in Q1 2026, selling an estimated $88.9K and leaving 73,400 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #3909.

Ameriprise first reported a position in PETS in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.7M in Q4 2017. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • Ameriprise held 73,400 shares of PetMed Express worth $167K as of Q1 2026.
  • Ameriprise sold 30,600 PetMed Express shares in Q1 2026, an estimated $88.9K.
  • PetMed Express made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3909 holding.
  • Ameriprise first reported a position in PetMed Express in Q2 2013 and has held it in 51 quarters since.
  • Ameriprise's PetMed Express position peaked at $12.7M in Q4 2017.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.